loader2
Login Open ICICI 3-in-1 Account
Open ICICI 3-in-1 Account

Best Agrolife Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Best Agrolife Ltd. 07 Aug 2025 16:17 PM
Result PDF

Q1FY26 Quarterly Result Announced for Best Agrolife Ltd.

Agrochemicals company Best Agrolife announced Q1FY26 results

  • Gross margin improved to 29% from 25%, driven by a superior product mix and cost discipline.
  • EBITDA margin rose to 12%, up 140 bps YoY.
  • PAT margin increased to 5%, up from 4% in Q1FY25.
  • Sales returns significantly reduced, improving profitability and inventory hygiene.
  • Revenue stood at Rs 381 crore, compared to Rs 519 crore in Q1FY25 due to deferred placements.
  • PAT remained steady at Rs 20 crore, despite lower topline.
  • Operating Expenses reduced due to strategic regional restructuring.

Vimal Kumar, Managing Director, Best Agrolife, said: “This monsoon we observed a mixed season with most parts of India witnessing normal to above normal rainfall with the exception of Telangana and Maharashtra. In certain regions this variability impacted sowing activity. Despite these regular climatic variations, this is a fair year for agriculture. We are pleased to report that our newly launched patented products are performing well in their debut season.

This quarter we have taken multiple steps to strengthen our sales performance from the ground up. Given our path to a disciplined approach in sales, we are reducing inventories and improving margins. As per our expectation, we have seen a margin improvement on a lower base of Q1 revenue numbers when compared QoQ.

We view this in alignment with our strategic decision to implement revised sales policies with the aim to increase profitability, reduce excess placements, and reduce inventory levels across the value chain.

Despite delayed monsoons affecting sowing in key regions, our newly launched patented products—Shot Down, Fetagen, and Best Man (along with Hustler, Suflex, and Executive under the Sudarshan Farm brand)—delivered good first-season performance. Field-level feedback has been positive. Shot Down and Hustler alone have already covered over 5 lakh acres, a strong testament to the trust we’ve earned among farmers and trade partners.

Demand for Fetagen and Suflex continues to accelerate in paddy, sugarcane, and vegetable segments.

We remain confident that our strong product portfolio, enhanced margins, and disciplined in-season execution will help sustain momentum through the remainder of the Kharif season.”

Result PDF

Result PDF

Agrochemicals company Best Agrolife announced Q2FY25 results

Financial Highlights:

  • Q2FY25 Revenue from Operations declined by 8% YoY to Rs 746.6 crore in Q2FY25 compared to Rs 811.2 crore in Q2FY24 due to lesser sprays on account of continuous rains and a strategic higher focus on branded sales. Branded sales contributed 65% to the overall revenue as compared to 53% in Q2FY24.
  • Q2FY25 EBITDA was at Rs 147.1 crore compared to Rs 144.1 crore in Q2FY24. EBITDA margin stood at 19.7% with an increase of 193 Bps on YoY basis, mainly on account of stability in raw material prices & higher sales of branded products.
  • Q2FY25 PAT stood at Rs 94.7 crore compared to Rs 94.9 crore in Q2 FY24.
  • As on Q2FY25, the Net Debt to equity has improved to 0.59 as compared to 0.90 as on FY24.

Business Highlights:

  • The Company was granted a patent for its novel ternary pesticide formulation that integrates lsoprothiolane, Pymetrozine, and Trifloxystrobin; as well as one for its fungicide formulation that combines Trifloxystrobin and Valifenalate.
  • Best Agrolife received a patent for innovative insecticide formulation 'Nemagen' that combines Chlorantraniliprole, Novaluron, and Emamectin Benzoate.
  • The Company received regulatory approval for Nemagen, an insecticide formulation called to target resistant pests causing major crop damage.

Vimal Kumar, Managing Director, Best Agrolife said: "We are pleased to announce that Best Agrolife Ltd. has delivered a strong performance in Q2FY25, capitalizing on fovorable market conditions and executing our strategic shift toward branded sales. Our commitment to enhancing brand visibility and expanding our morket presence has yielded positive results, contributing significantly to both topline ond bottomline growth.

During H1FY25, we secured three key patents for our innovotive formulations, reinforcing our leadership in the crop protection segment. Our branded products continued to perform exceptionolly well across regions, driving overall revenue growth. As a result of these efforts, we saw a substantial improvement in profitability, with our margins expanding from 26% to 34% YoY.

Due to our effective working capital management, we have seen a significant improvement in cash flow from operating activities, rising from 15 crores in H1FY24 to <725 crores in H1FY25, reflecting our ongoing focus on optimizing financial performance.

A notable achievement has been the effective manogement of sales returns-a chollenge we faced in the previous fiscal year. By optimizing our supply chain to better align with channel demand, we successfully reduced sales returns, which are expected to remain significontly lower than last year. Furthermore, we have now fully liquidated our high-cost inventory, positioning us for a more agile and responsive appraoch to future market dynamics.

Although seosonal conditions were generally more fovorable compared to last year, some regions experienced excessive and continuous roinfall, which resulted in fewer crop sprays. However, the overall impact of above-average rainfall has been largely positive, particularly in key agricultural regions. lndia's water reservoirs are currently at 88% of total capacity-14% above normal levels-creating a strong foundation for the upcoming Rabi seoson. ln regions such as Maharashtra, Karnataka, Andhra Pradesh, and Telangana, where live water storage levels exceed 90%, we anticipate robust agricultural activity, setting the stoge for a highly productive second half of the fiscal year.

Looking ahead, we are excited about our strong product pipeline for Q3 and Q4FY25. ln the upcoming quarter, we plan to launch our patented herbicide 'Shot Down' alongside a new insecticide. Additionally, two more cutting-edge insecticides are slated for release in Q4, further strengthening our product portfolio and market competitiveness.

As we move forward, Best Agrolife remains committed to leveraging innovotion, expanding brand presence, and maintaining fiinancial discipline to drive sustainable growth in the coming quorters."

Result PDF

Agrochemicals company Best Agrolife announced Q1FY25 results: 

  • Revenue from Operations declined by 15.2% YoY to Rs 519.3 crore in Q1FY25 compared to Rs 612.2 crore in Q1FY24 on the back of a delay in monsoon during the later part of June and clearance of expensive inventory built in Q4 FY24. At the same time, Branded sales contributed 63% to the overall revenue as against 55% in Q1FY24, in line with the strategy to focus on building the branded business. Although, the monsoon set in early but the dry spell in June resulted in the postponement of sales from Q1 to Q2.
  • Q1FY25 EBITDA was at Rs 54.6 crore compared to Rs 130.0 crore in Q1FY24. This is not only due to a decline in revenues but also due to the liquidation of expensive inventory carried from Q4FY24 and the strategic shift to branded sales from institutional sales, which led to higher employee & other expenses.
  • Q1FY25 PAT stood at Rs 21.3 crore compared to Rs 90.5 crore in Q1FY24

Commenting on the result and overall update on the Q1FY25, Vimal Kumar, Managing Director, Best Agrolife said, “The early arrival of the monsoon in India has boosted positive sentiments in the agricultural sector. La Niña conditions are expected to intensify in the latter half of the monsoon season, compensating for the current precipitation deficiency. As of June 28, 2024, Kharif sowing had surged by 10% year-on-year, reaching 58 million hectares, driven primarily by the increased cultivation of pulses, oilseeds, and cotton. This should boost EBITDA for agrochemical companies in the coming quarters. Inventory de-stocking issues should improve with the good monsoon, as higher demand and improved volumes have helped companies liquidate excess inventory in Q1FY25.

During the quarter, Best Agrolife achieved key milestones, including launching the patented product "Orisulam" and introducing "Nemagen," expanding our agrochemical solutions. Additionally, we secured a patent for a Stable Synergistic Pesticidal Composition, highlighting our commitment to innovation and sustainability. These advancements demonstrate our dedication to providing cutting-edge solutions and supporting farmers with reliable products.

We have entered the new fiscal year with an optimistic outlook, focusing on delivering value to farmers through R&D. We believe that with a good monsoon, we will be able to achieve our growth targets. Our strategic shift to focus more on branded business is on track, enabling us to add value in the long term.

I thank all our stakeholders for their continued support and faith in our company.”

Result PDF

Agrochemicals company Best Agrolife announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue from Operations declined by 46.68% YoY to Rs 135.39 crore in Q4FY24 compared to Rs 253.91 crore in Q4FY23, due to an unexpected seasonal failure, of Q3 and Q4 of FY24 as against normal seasonal conditions in same period last year, leading to lower-than-expected sales coupled with surge in sales returns
  • Q4FY24 EBITDA (excluding Other Income) was a loss of Rs 67.10 crore against a profit of Rs 7.14 crore in Q4FY23
  • Q4FY24 PAT stood at loss of Rs 72.49 crore against a loss of Rs 8.41 crore in Q4FY23, caused by price erosion and our investments in brand building

FY24 Financial Highlights:

  • Revenue from Operations grew by 7.31% to Rs 1,873.32 crore in FY24 compared to Rs 1,745.68 crore in FY23. This is mainly due to significant growth in branded sales as compared to the previous corresponding period
  • FY24 EBITDA (excluding Other Income) was at Rs 225.59 crore against Rs 313.66 crore in FY23, a decline of 28.08% on YoY basis. This is mainly due to shift in business strategy from institutional sales to branded sales, which has resulted in higher employee costs and other expenses. The increase in employee costs is attributable to the strategic investment in manpower to expand the dealer network. Additionally, other expenses have increased due to incremental travel and marketing expenses
  • FY24 PAT stood at Rs 106.27 crore.
  • The Board recommended a final Dividend, subject to approval of shareholders, of Rs 3 (30%) per equity of face value Rs 10

Commenting on the result and overall update on the financial year 2023-2024, Vimal Kumar, Managing Director, Best Agrolife Ltd. said, “Despite the many challenges faced during the year, for the full year FY24, our revenue grew by 7% on YoY basis. This growth was driven by our shift in business strategy from institutional sales to branded sales. This has resulted in the growth of our branded business by 85%. However, the EBITDA margins reduced to 12% in FY24, mainly because of the stress on the gross margin due to pricing pressures in the market, primarily caused by oversupply from China. Combination of weather factors, our shift towards branded products, and an expanding distributor network led to higher trade inventory.

Additionally, employee costs have gone up due to a shift in business strategy. The planned increase in employee cost is a strategic investment to strengthen our sales distribution network. Also, other expenses have risen due to incremental marketing costs for focus on branded business.

Despite the high competition from imports, particularly pricing pressure from China and the challenges posed by the global economic climate, we have maintained good profit margins.

This year, our company achieved several significant operational milestones. We became a major partner in Kashmir Chemicals by acquiring a 99% stake, increasing our formulation capacities. Our strategic acquisition of Sudarshan Farm Chemicals will allow us to leverage SFCL’s robust R&D capabilities, IP portfolio, and backward-integrated technical manufacturing expertise. These developments will be crucial in enhancing our manufacturing and innovation capabilities.

The company continues to build upon a strong registration portfolio having garnered 94 registrations for newer technicals and formulations in FY’24. We have established a strong foundation for accelerated growth by securing patents for newer groundbreaking products. In FY’24 we launched multiple products, including our patented formulation “Tricolor”. Our past investments in research will see us launching multiple patented products such as “Warden Extra”, “Defender”, “Orisulam” and potentially “Shot Down” in FY’25. The new additions to our patent portfolio will see us reaping the fruits of our investments in FY’25 and beyond.

We continue to strategically expand our R&D capabilities with potential yieldsin the upcoming years. We are committed to developing safer and newer chemistries that are beneficial for the farmer and the environment. With a robust pipeline of new innovative and patented products coupled with an increased market presence, we are well-positioned to capitalize on emerging opportunities and drive value for our shareholders.

We have entered the new fiscal year with an optimistic outlook with our focus on delivering value to the farmer through R&D.

I thank all our stakeholders for their continued support and faith in our company.”

Result PDF

Agrochemicals company Best Agrolife announced Q2FY24 & H1FY24 results:

  • Q2FY24:
    • Revenue from operations for Q2FY24 stood at Rs 811 crore which grew by 32% QoQ and 16% on a YoY basis compared to Rs 612 crore in Q1FY24 and Rs 700 crore in Q2FY23. 
    • EBITDA for Q2FY24 came at Rs 144 crore up 11% QoQ and de-grew 21% YoY compared to Rs 130 crore in Q1FY24 and Rs 183 crore in Q2FY23. The improvement in EBITDA for the quarter was due to a better product mix.
    • EBITDA margin for Q2FY24 came at 18% as compared to 21% in Q1FY24 and 26% in Q2FY23, down 300 bps QoQ and down 800 bps YoY.
    • PAT for Q2FY24 was at Rs 95 crore, up 5% QoQ and down 27% YoY compared to Rs 91 crore in Q1FY24 and Rs 130 crore in Q2FY23.
    • PAT margin for Q2FY24 came at 12% as compared to 15% in Q1FY24 and 19% in Q2FY23, down 300 bps QoQ and down 700 bps YoY.
  • H1FY24:
    • Revenue from operations for H1FY24 stood at Rs 1,423 crore which grew by 22% on a YoY basis compared to Rs 1,164 crore in H1FY23.
    • EBITDA for H1FY24 came at Rs 274 crore up 10% YoY compared to Rs 248 crore in H1FY23. The improvement in EBITDA was driven by a better product mix during H1FY24.
    • EBITDA margin for H1FY24 was at 19% as compared to 21% in H1FY23, down 200 bps YoY.
    • PAT for H1FY24 came at Rs 185 crore up 9% YoY compared to Rs 170 crore in H1FY23
    • PAT margin for H1FY24 was at 13% as compared to 15% in H1FY23, down 200 bps YoY.

 

 

Result PDF

Agrochemicals company Best Agrolife announced consolidated Q1FY24 results:

  • Revenue from operations for Q1FY24 stood at Rs 612 crore which grew by 141% QoQ and 32% on a YoY basis compared to Rs 254 crore in Q4FY23 and Rs 464 crore in Q1FY23
  • Gross margin for Q1FY24 is at 30% as compared to 19% in Q4FY23 and 21% in Q1FY23 which was an expansion of 1,100 bps QoQ and an expansion of 900 bps YoY.
  • EBITDA for Q1FY24 came at Rs 130 crore up 1,720% QoQ and 97% YoY compared to Rs 7 crore in Q4FY23 and Rs 66 crore in Q1FY23. The improvement in EBITDA was driven by a better product mix during Q1FY24.
  • EBITDA margin for Q1FY24 came at 21% as compared to 3% in Q4FY23 and 14% in Q1FY23 which was an expansion of 1,800 bps QoQ and an expansion of 700 bps YoY.
  • PAT for Q1FY24 was at Rs 90 crore, up 1,168% QoQ and 124% YoY compared to Rs (8) crore in Q4FY23 and Rs 40 crore in Q1FY23.
  • PAT margin for Q1FY24 came at 15% as compared to (3%) in Q4FY23 and 9% in Q1FY23 which was an expansion of 1,800 bps QoQ and an expansion of 600 bps YoY.

Commenting on results, Vimal Kumar, Managing Director, Best Agrolife, said: “I am delighted to share that Best Agrolife has achieved remarkable growth momentum, with revenue from operations growing by 32% YoY to Rs 612 crore, despite the headwinds that the agrochemicals industry has been facing. Our herbicide portfolio products including Amito, Propique, Tombo, Ronfen, and Warden have been the driving force behind this quarter's growth. Additionally, our EBITDA margins of 21% can be attributed to the increasing contribution of speciality, niche, and patented products to our overall revenue.

This quarter's performance also reinforces the widespread acceptance of our products and Best Agrolife's strong brand presence in the Indian agrochemical market. Focusing on FY24, we have already launched a couple of technicals in Q1, which are seeing promising traction, with plans to introduce one patented product in Q2. Our pipeline for technical and niche formulations is geared up for launch over the next few quarters.

While the agrochemicals industry continues to face challenges, I firmly believe that our niche product basket will not only shield us from industry perils but also drive robust growth in FY24. This gives us a reason to remain steadfast in our commitment to achieving a 30% growth target and maintaining 20% EBITDA margins for FY24.”

 

 

Result PDF

Agrochemicals company Best Agrolife announced FY23 results:

  • Revenue from operations for FY23 grew by 44% YoY to Rs 1,746 crore.
  • Gross margin for the year is at 28% as compared to 19% in FY22 which was an expansion of 963 bps YoY. 
  • EBITDA for the year came at Rs 314 crore up 89% YoY compared to Rs 166 crore in FY22. 
  • EBITDA margin for the year came at 18% as compared to 14% in FY22; expansion of 427 bps YoY. 
  • PAT for FY23 was at Rs 192 crore up 83% on a YoY basis. PAT margin for the year was at 11% compared to 9% in FY22.

Commenting on results, Vimal Alawadhi, Managing Director, Best Agrolife, said: “I am delighted to inform you that we have delivered strong revenue from operations of Rs 1,746 crore. which is a robust growth of 4% over FY22. Our constant focus on introducing innovative products to cater to farmers' needs has resulted in BAL introducing many specialised combination products including a patented novel combination Ronfen in FY23 which drove growth during the year. We have also expanded our margins by 427 bps during the year which was driven by a change in product mix.

Happy to mention, Board has recommended a dividend of 30% (i.e. Rs3 per share), which is a 50 % jump over last year.

Q4FY23 was difficult for the industry at large due to higher channel inventory and excess supply from China at lower prices. We were also affected by this as our branded product portfolio is more focused on the Kharif season. We are working towards introducing more branded products that are focused on the Rabi season which will improve the breadth of the portfolio and will also make the portfolio more balanced which is currently skewed more towards the kharif season.

In line with our commitment to “Make in India”, we have embarked on a capex plan to expand our technical capabilities as well as improve backward integration which will lead to lower dependence on China and a better cost structure.

Overall, we have an exciting product pipeline ready to be launched in FY24 which is in line with our strategy of introducing more patented and specialised combination products which will help continue strong growth momentum as well as improve our margins in FY24.”

 

Result PDF

Best Agrolife announced Q3FY23 results:

  • Consolidated Q3FY23:
    • The company recorded revenue of Rs 327.8 crore, a growth of 41% as against Rs 232.5 crore in Q3FY22.
    • EBITDA at Rs 58.1 crore grew significantly by 79.1% as against Rs 32.43 crore in Q3FY22. EBITDA margin for the quarter at 17.7% as against 13.9% in Q3FY22.
    • PAT at Rs 30.6 crore as against Rs 15.24 crore in Q3FY22 a robust growth of 100.8%.
  • Consolidated 9MFY23:
    • The company recorded revenue of Rs 1,491.8 crore in 9MFY23, a growth of 65.5 % as against Rs 901.4 crore in 9MFY22.
    • EBITDA at Rs 1,306.5 crore grew significantly by 195.5% as against Rs 103.7 crore last year. EBITDA margin for 9M stood at 20.5% as against 11.5% last year.
    • PAT at Rs 200.6 crore as against Rs 66.4 crore in 9MFY22 a robust growth of 202.2%

Mr. Vimal Alawadhi, Managing Director of Best Agrolife Limited, commenting on the performance for the quarter and nine-month ended December 2022 said, "We are glad to share that despite being a lean season BAL successfully managed to remain consistent with its performance in the third quarter of this financial year. While the company has shown growth with a positive outlook across all the business segments during this period. We are focussed on our g oba export expansion which wi I start reflecting in our revenue growth soon. The company plans to introduce new and exclusive patented products like Ronfen and other different segment products which will scale up our growth manifolds in the coming years. It is important to note that BAL recently obtained registration for the indigenous manufacturing of Cyhalofop-butyl and Propaquizafop Technical u/s 9(3) along with several crucial technical".

 

Result PDF

Agrochemicals company Best Agrolife announced Q2FY23 results:

  • Q2FY23:
    • The company recorded revenue of Rs 700.3 crore, a growth of 115.9 % as against Rs 324.38 crore in Q2FY22. On Sequential basis revenue grew by 51%( Rs 700.3 crore against Rs 463.7 crore).
    • EBITDA at Rs182.5 crore grew significantly by 418.1% as against Rs 35.23 crore in Q2FY22 . On sequential basis EBITDA grew by 176.9% ( Rs 182.5 crore against Rs 65.9 crore);
    • EBITDA margin for the quarter at 26.1% as against 10.9% in Q2FY22 and 14.2% in Q1FY23
    • PAT at Rs 129.82 crore as against Rs 25.19 in Q2FY22 a robust growth of 415.4%. On Sequential basis PAT grew by 223.4% (Rs 125.85 crore against Rs 40.1 crore).
  • H1FY23:
    •  The company recorded revenue of Rs 1164 crore in H1FY23, a growth of 74 % as against Rs 668.9 crore in H1FY22
    • .EBITDA at Rs 248.4 crore grew significantly by 248.4% as against Rs 71.3 Crore in H1FY22. EBITDA margin for H1 stood at 21.3% as against 10.7% in H1FY22
    • PAT at Rs 169.9 crore as against Rs 51.1 crore in H1FY22 a robust growth of 232.3 %

Mr. Vimal Alawadhi, Managing Director of Best Agrolife Limited, commented on the results, "We are delighted with the stellar performance delivered in H1FY23. The highlight of this quarter was the tremendous success of our newly launched products - specially Ronfen, AxeMan, and Warden. Our plants have achieved higher capacity utilization and we have many revolutionary products in the pipeline."

"BAL is a purely research-based company. Our robust R&D team specializes in innovating new molecules that get certified by the respective govt authorities and renowned universities. We have crafted a niche for ourselves in the agrochemical industry by receiving one or two patents for significant formulations consecutively in the last few years. To seize future market opportunities and increase our competitiveness we focus on leveraging our innovation power for agro-inputs in order to come up with tailor-made crop solutions to the specific problems and needs of the farmers," he added further

 

Result PDF

Best Agrolife announced Q1FY23 results:

  •  The company recorded revenue of Rs 463.7 crore, a growth of 34.6% as against Rs 344.6 crore in Q1FY22. On Sequential basis revenue grew by 49.9%.
  • EBITDA at Rs 65.9 crore grew significantly by 82.7% as against Rs 36.06 crore in Q1FY22; EBITDA margin for the quarter at 14.2 % as against 10.5% in Q1FY22
  • PBT at Rs 53.4 crore, a growth of 53.5% YoY & 8.4% on QoQ basis
  • PAT also registered a robust growth of 54.7% YoY at Rs 40.1 Crore in comparison to Rs 25.94 crore reported in Q1FY21 

Mr. Vimal Alawadhi, Managing Director of Best Agrolife Limited, commented on the results, “We are pleased to inform you that after closing FY2022 with strong results we have succeeded in maintaining our upward growth momentum in the first quarter of the current fiscal year as well. Due to our futuristic vision, discipline, and carefully crafted strategy we improved on FY22 EBITDA margins despite the inflationary pressure. During this quarter we launched many new revolutionary products including our patented product RONFEN. The initial response has been good and we expect a pick-up in the next quarter. On the other hand, we also focused on strengthening our team by bringing some extremely talented professionals like Mr Pramod N Karlekar, a renowned technocrat in the chemical arena on board which will surely prove to be fruitful for the organization in the long run.”

 

Result PDF

Trending News

Midhani has secured an order of Rs. 121.75 crore

Midhani has secured an order of Rs. 121.75 crore

Published on 19-Dec-2025 09:02

Aeroflex Industries Board has approved a ₹97.56 crore expansion plan

Aeroflex Industries Board has approved a ₹97.56 crore expansion plan

Published on 19-Dec-2025 09:01

As per media sources, HDFC Bank has raised a $1 billion three-year overseas loan from its GIFT City branch

As per media sources, HDFC Bank has raised a $1 billion three-year overseas loan from its GIFT City branch

Published on 19-Dec-2025 09:00

TCS, on its Investor Day 2025, articulated a clear shift towards an AI-first enterprise

TCS, on its Investor Day 2025, articulated a clear shift towards an AI-first enterprise

Published on 18-Dec-2025 09:07

Syrma SGS Technology has completed the first tranche of its acquisition of defence and aerospace electronics firm Elcome Integrated Systems

Syrma SGS Technology has completed the first tranche of its acquisition of defence and aerospace electronics firm Elcome Integrated Systems

Published on 18-Dec-2025 09:06

POWERGRID has commissioned the Western Region Expansion Scheme-XXV

POWERGRID has commissioned the Western Region Expansion Scheme-XXV

Published on 18-Dec-2025 09:05

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app
✕
Application status